Trends in stereotactic body radiation therapy for stage I small cell lung cancer

Highlights • SBRT utilization for stage I SCLC has increased over the last decade. • This has occurred despite a lack of national guidelines or data supporting its use. • Radiation dose prescription trends mirror that of SBRT in NSCLC. • The role of SBRT for inoperable cT1-2 N0 SCLC requires further...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Lung cancer (Amsterdam, Netherlands) Netherlands), 2017-01, Vol.103, p.11-16
Hauptverfasser:	Stahl, John M, Corso, Christopher D, Verma, Vivek, Park, Henry S, Nath, Sameer K, Husain, Zain A, Simone, Charles B, Kim, Anthony W, Decker, Roy H
Format:	Artikel
Sprache:	eng
Schlagworte:	Aged Aged, 80 and over Female Follow-Up Studies Hematology, Oncology and Palliative Medicine Humans Lung Neoplasms - drug therapy Lung Neoplasms - pathology Lung Neoplasms - radiotherapy Male Medically inoperable NCDB Neoplasm Staging Pulmonary/Respiratory Radiosurgery - methods Radiosurgery - trends Radiotherapy Dosage Retrospective Studies SBRT SCLC Small Cell Lung Carcinoma - drug therapy Small Cell Lung Carcinoma - pathology Small Cell Lung Carcinoma - radiotherapy Stage I Survival Rate United States - epidemiology
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Beschreibung
Zusammenfassung:	Highlights • SBRT utilization for stage I SCLC has increased over the last decade. • This has occurred despite a lack of national guidelines or data supporting its use. • Radiation dose prescription trends mirror that of SBRT in NSCLC. • The role of SBRT for inoperable cT1-2 N0 SCLC requires further research.
ISSN:	0169-5002 1872-8332
DOI:	10.1016/j.lungcan.2016.11.009